Home Nanite

Nanite

In operation
-
Provider of AI-Driven Polymer Design Platforms
Basic
Enterprise Profile

Basic Information

Nanite is a non-viral gene delivery company that develops programmable polymer nanoparticles for a range of models and indications. Its AI-driven platform, SAYER, combines automated polymer synthesis and high-throughput in vivo screening with machine learning to design "programmable" polymer nanoparticles (PNPs) capable of delivering a wide variety of genetic cargoes with tissue specificity. The company plans to collaborate with gene medicine companies and patient advocacy groups to develop delivery tools for various indications as part of its Delivery-as-a-Service (DaaS) collaboration model.
Nanite, Inc.
Boston,Massachusetts,United States of America
15~50 people
--
careers@nanitebio.com

Enterprise Profile

Industrial Sector
New Drug Development CXO (Pharmaceutical Outsourcing Organization)
Technology
Artificial Intelligence
Application Scenarios
Innovative Drugs AI+Pharmaceuticals